Author/Authors :
Farshidi, Hossein Cardiovascular Research Center - Hormozgan University of Medical Sciences, Bandar Abbas, IR Iran , Abdi, Ahmadnoor Cardiovascular Research Center - Hormozgan University of Medical Sciences, Bandar Abbas, IR Iran , Boland, Abdollah Cardiovascular Research Center - Hormozgan University of Medical Sciences, Bandar Abbas, IR Iran , Moshiri, Shahram Interventional Cardiovascular Unit - Santa Corona General Hospital, Pietra Ligure, Italy , Nicolino, Annamaria Interventional Cardiovascular Unit - Santa Corona General Hospital, Pietra Ligure, Italy , Nikparvar, Marzieh Cardiovascular Research Center - Hormozgan University of Medical Sciences, Bandar Abbas, IR Iran , Azad, Mohsen Cardiovascular Research Center - Hormozgan University of Medical Sciences, Bandar Abbas, IR Iran , Eghbal Eftekhari, Tasnim Molecular Medicine Research Center - Hormozgan University of Medical Sciences, Bandar Abbas, IR Iran
Abstract :
Background: Primary percutaneous coronary intervention (PPCI) is the gold standard for the treatment
of ST-segment-elevation myocardial infarction (STEMI). Guidelines emphasize the importance
of STEMI networks in order to facilitate rapid acute reperfusion therapy and improve prognosis.
The outcomes of PPCI in a single tertiary university hospital in Hormozgan Province in Iran are
reported herein.
Methods: We performed an observational study including all the consecutive STEMI cases admitted to
our interventional cardiology department. Symptom to door, door to ECG, door to diagnosis,
door to cath lab, door to balloon, and mortality were reported. Descriptive statistics (median,
quartile 1-3) and nonparametric tests (Kruskal–Wallis and Mann–Whitney) were used.
Results: Totally, 195 patients were considered eligible for PPCI. The mean age of the patients was
54.90 years old (range =21–91 y). Women accounted for 28.2% of the study population. All the
patients successfully underwent PPCI with a 100% rate of stenting. The in-hospital mortality
rate was 1.45%. The median time for symptom-to-door, door-to-diagnosis, code-activation,
symptom-to-device, and door-to-device times was 167.50, 23, 35, 266, and 60 minutes,
respectively.
Conclusions: Our results, in line with previous studies, confirm the role of PPCI as the frontline
approach to STEMI. Our results display the continuous efforts provided to reduce the inhospital
procedural times; nevertheless, ongoing efforts are needed to decrease symptom-todoor
times.